[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Research Report 2024(Status and Outlook)

February 2024 | 124 pages | ID: G18EBD4FCF70EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

Non-alcoholic steatohepatitis is an advanced stage of non-alcoholic fatty liver disease (NAFLD), which arises when the excess fat accumulation causes inflammation and damage leading to liver scarring. A biomarker is the most effective diagnosis tool for measuring the biological state and is termed as an indicator for measuring normal biological processes and pathogenic process in the body.

This report provides a deep insight into the global NASH (Non-alcoholic Steatohepatitis) Biomarkers market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NASH (Non-alcoholic Steatohepatitis) Biomarkers market in any manner.

Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GENFIT SA

Gilead Sciences, Inc. (GILD)

AstraZeneca

Novartis AG

Bristol-Myers Squibb Company

Allergan Plc

Novo Nordisk A/S

Boehringer Ingelheim

Pfizer Inc

Market Segmentation (by Type)

Serum Biomarkers

Hepatic Fibrosis Biomarkers

Apoptosis Biomarkers

Oxidative Stress Biomarkers

Others

Market Segmentation (by Application)

Pharma & CRO Industry

Hospitals

Diagnostic Labs

Academic Research Institutes

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
  • Overview of the regional outlook of the NASH (Non-alcoholic Steatohepatitis) Biomarkers Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NASH (Non-alcoholic Steatohepatitis) Biomarkers Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of NASH (Non-alcoholic Steatohepatitis) Biomarkers
1.2 Key Market Segments
  1.2.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Type
  1.2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET COMPETITIVE LANDSCAPE

3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Manufacturers (2019-2024)
3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Manufacturers (2019-2024)
3.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Sites, Area Served, Product Type
3.6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Competitive Situation and Trends
  3.6.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Concentration Rate
  3.6.2 Global 5 and 10 Largest NASH (Non-alcoholic Steatohepatitis) Biomarkers Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS INDUSTRY CHAIN ANALYSIS

4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2019-2024)
6.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Market Share by Type (2019-2024)
6.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Type (2019-2024)

7 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Sales by Application (2019-2024)
7.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD) by Application (2019-2024)
7.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate by Application (2019-2024)

8 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET SEGMENTATION BY REGION

8.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region
  8.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region
  8.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region
8.2 North America
  8.2.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 GENFIT SA
  9.1.1 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.1.2 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.1.4 GENFIT SA Business Overview
  9.1.5 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
  9.1.6 GENFIT SA Recent Developments
9.2 Gilead Sciences, Inc. (GILD)
  9.2.1 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.2.2 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.2.4 Gilead Sciences, Inc. (GILD) Business Overview
  9.2.5 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
  9.2.6 Gilead Sciences, Inc. (GILD) Recent Developments
9.3 AstraZeneca
  9.3.1 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.3.2 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.3.4 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
  9.3.5 AstraZeneca Business Overview
  9.3.6 AstraZeneca Recent Developments
9.4 Novartis AG
  9.4.1 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.4.2 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.4.4 Novartis AG Business Overview
  9.4.5 Novartis AG Recent Developments
9.5 Bristol-Myers Squibb Company
  9.5.1 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.5.2 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.5.4 Bristol-Myers Squibb Company Business Overview
  9.5.5 Bristol-Myers Squibb Company Recent Developments
9.6 Allergan Plc
  9.6.1 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.6.2 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.6.4 Allergan Plc Business Overview
  9.6.5 Allergan Plc Recent Developments
9.7 Novo Nordisk A/S
  9.7.1 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.7.2 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.7.4 Novo Nordisk A/S Business Overview
  9.7.5 Novo Nordisk A/S Recent Developments
9.8 Boehringer Ingelheim
  9.8.1 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.8.2 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.8.4 Boehringer Ingelheim Business Overview
  9.8.5 Boehringer Ingelheim Recent Developments
9.9 Pfizer Inc
  9.9.1 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
  9.9.2 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
  9.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Market Performance
  9.9.4 Pfizer Inc Business Overview
  9.9.5 Pfizer Inc Recent Developments

10 NASH (NON-ALCOHOLIC STEATOHEPATITIS) BIOMARKERS MARKET FORECAST BY REGION

10.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast
10.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country
  10.2.3 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Region
  10.2.4 South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2025-2030)
  11.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2025-2030)
11.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Application (2025-2030)
  11.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) Forecast by Application
  11.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Comparison by Region (M USD)
Table 5. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH (Non-alcoholic Steatohepatitis) Biomarkers as of 2022)
Table 10. Global Market NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Sites and Area Served
Table 12. Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Type
Table 13. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NASH (Non-alcoholic Steatohepatitis) Biomarkers
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Challenges
Table 22. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (K Units)
Table 23. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Type (M USD)
Table 24. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Type (2019-2024)
Table 25. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2019-2024)
Table 26. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD) by Type (2019-2024)
Table 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Share by Type (2019-2024)
Table 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price (USD/Unit) by Type (2019-2024)
Table 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Application
Table 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Application
Table 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2019-2024) & (K Units)
Table 32. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2019-2024)
Table 33. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2019-2024) & (M USD)
Table 34. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2019-2024)
Table 35. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate by Application (2019-2024)
Table 36. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2019-2024) & (K Units)
Table 37. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2019-2024)
Table 38. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2019-2024) & (K Units)
Table 39. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2019-2024) & (K Units)
Table 41. South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2019-2024) & (K Units)
Table 43. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 44. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 45. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GENFIT SA Business Overview
Table 47. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
Table 48. GENFIT SA Recent Developments
Table 49. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 50. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 51. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gilead Sciences, Inc. (GILD) Business Overview
Table 53. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
Table 54. Gilead Sciences, Inc. (GILD) Recent Developments
Table 55. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 56. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 57. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 62. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 63. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Recent Developments
Table 66. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 67. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 68. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Company Business Overview
Table 70. Bristol-Myers Squibb Company Recent Developments
Table 71. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 72. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 73. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Allergan Plc Business Overview
Table 75. Allergan Plc Recent Developments
Table 76. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 77. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 78. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novo Nordisk A/S Business Overview
Table 80. Novo Nordisk A/S Recent Developments
Table 81. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 82. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 83. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Basic Information
Table 87. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Overview
Table 88. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Inc Business Overview
Table 90. Pfizer Inc Recent Developments
Table 91. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of NASH (Non-alcoholic Steatohepatitis) Biomarkers
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD), 2019-2030
Figure 5. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (M USD) (2019-2030)
Figure 6. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Country (M USD)
Figure 11. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Manufacturers in 2023
Figure 12. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers in 2023
Figure 13. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Type
Figure 18. Sales Market Share of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2019-2024)
Figure 19. Sales Market Share of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type in 2023
Figure 20. Market Size Share of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2019-2024)
Figure 21. Market Size Market Share of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application
Figure 24. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2019-2024)
Figure 25. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application in 2023
Figure 26. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2019-2024)
Figure 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application in 2023
Figure 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate by Application (2019-2024)
Figure 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2019-2024)
Figure 30. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2023
Figure 32. U.S. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2023
Figure 37. Germany NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region in 2023
Figure 44. China NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (K Units)
Figure 50. South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2023
Figure 51. Brazil NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Forecast by Type (2025-2030)
Figure 65. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Application (2025-2030)
Figure 66. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Forecast by Application (2025-2030)


More Publications